ArticlebioRxiv : the preprint server for biology2026
Direct Mapping of CDK2 Substrates in Embryonic Stem Cells Uncovers an AP-Site Repair Mechanism via HMCES Phosphorylation.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Embryonic stem cells (ESCs) proliferate rapidly while robustly maintaining genomic integrity and exhibiting high cell-cycle kinase activity. How this activity contributes to genome integrity remains unclear. Here, using mouse ESCs engineered to express an analog-sensitive CDK2, we combine thiophosphate labeling with mass spectrometry to define a high-confidence CDK2 substrate landscape. We uncovered 65 CDK2 substrates in total, including both known and previously unrecognized substrates. Among these, HMCES, a sensor of apurinic/apyrimidinic (AP) sites, was identified as a specific cyclin E-CDK2 substrate. We mapped three CDK2-dependent phosphorylation sites in HMCES and showed that phosphorylation of these sites decreased HMCES binding to ssDNA. Mutational analysis further revealed that HMCES docks to cyclin E-CDK2 complexes via the hydrophobic patch on cyclin E. Finally, we demonstrated that HMCES phosphorylation contributes to AP-site repair and promotes ESC proliferation. Together, our findings uncover a CDK2-HMCES signaling axis that links rapid cell-cycle progression to the preservation of genome stability in mouse ESCs.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.